Pharmaron Beijing Co Ltd - ESG Rating & Company Profile powered by AI
Complete ESG analysis of Pharmaron Beijing Co Ltd are reached by logging in. Alternative companies in the rating peer group for Pharmaron Beijing Co Ltd are shown. Check the bottom of the page for potential risks for Pharmaron Beijing Co Ltd based on sector, geography and marketcap.
Pharmaron Beijing Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.4; made up of an environmental score of 0.0, social score of 2.0 and governance score of 2.3.
1.4
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1715 | Polaris Group | 1.6 | Low |
| 1715 | RenovaCare Inc | 1.6 | Low |
| 1747 | Pharmaron Beijing Co Ltd | 1.4 | Low |
| 1747 | Chembio Diagnostics Inc | 1.4 | Low |
| 1747 | Genscript Biotech Corp | 1.4 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Pharmaron Beijing Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd offer flexible work?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose water use targets?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Pharmaron Beijing Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Pharmaron Beijing Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Pharmaron Beijing Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Pharmaron Beijing Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Pharmaron Beijing Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Pharmaron Beijing Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and Others. It offers laboratory chemistry solutions, including medicinal, synthetic, and analytical and purification chemistry, as well as computer-aided drug design services; bioscience services comprising in vitro and in vivo drug metabolism and pharmacokinetics/absorption, distribution, metabolism, and excretion solutions; and in vitro biology and in vivo pharmacology, safety assessment, and the U.S. laboratory services. The company also provides process development and manufacturing, material science/pre-formulation, formulation development and manufacturing, and analytical development services; and radiolabelled science services and early stage clinical trial services, as well as clinical research and site management services. It also provides business development; and contract research, development, and manufacturing services for pharmaceutical products. The company was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.